Akari Therapeutics Long Term Deferred Charges (Quarterly) Insights

Akari Therapeutics Plc (AKTX)

0.2366 0.00 (0.00%) USD | NASDAQ | Feb 20, 16:00

0.2419 +0.01 (+2.24%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for AKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

DBV Technologies SA	--
Cellectis SA	--
Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Autolus Therapeutics Plc	--